Blood Market Size, Share & Trends Analysis Report By Product (Whole Blood Collection and Processing, Source Plasma Collection, Blood Typing Products, Blood Screening Products), By End-User (Blood and Blood Component Bank, Diagnostics Laboratories, Ambulatory Surgical Centers, Hospitals, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Blood Market Size

The global blood market size was valued at USD 9.4 billion in 2025 and is projected to grow from USD 9.89 billion in 2026 to USD 14.78 billion by 2034, registering a CAGR of 5.16% during the forecast period from 2026 to 2034. Asia Pacific dominated the blood market with a market share of 36.8% in 2025.

Blood is a specialized and essential body fluid that comprises four major components, i.e., plasma, platelets, RBCs, and WBCs. Each component plays a vital role in various diagnostics and therapeutic applications, particularly for patients suffering from blood-related disorders such as cardiovascular diseases, cancer, and hematological conditions. This wide-ranging applicability fuels the growth of the global market.

Furthermore, the rising prevalence of trauma, accidents, and surgeries necessitates an increased demand for blood products. The surge in surgical procedures, combined with the growing incidences of trauma and chronic diseases, significantly contributes to the expanding market. Advancements in medical technologies, such as processing automation and storage systems, are also improving the safety and efficiency of RBC transfusions.

Segmentation Analysis

The Global Blood Market is Segmented into Product and End-User

By Product

Whole blood collection and processing segment dominates the market with the highest market revenue

The whole blood collection and processing segment leads the market due to the widespread applications of whole blood in treating chronic conditions like hematological disorders, kidney disease, and trauma-related blood loss. Whole blood is also essential for transfusions, especially in cancer treatment, surgical procedures, and emergencies.

• For instance, in June 2022, the WHO reported that 118.5 million units of donated hematic fluid are collected worldwide. However, there remains a significant need for more donations to meet global transfusion demands.

Request Customizationto receive a tailored report.

By End User

Blood and blood component bank segment dominates the market with the highest market revenue

The blood and blood component bank segment holds the largest blood market share by end users, driven by the critical role these facilities play in ensuring the availability and storage of blood in optimal conditions for future use. Blood banks not only store whole blood but also plasma, platelets, and other components, which are essential for a variety of medical treatments, including surgeries, cancer care, and trauma management. These facilities also facilitate key processes such as hematic fluid collection, screening, and processing, ensuring the safety and efficacy of hematic fluid products.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region with 35.67% Market Share

North America holds a dominant position in the global market, driven by advanced technologies in blood processing, screening, and blood-related devices that enhance clinical development for treating chronic illnesses. The region is at the forefront of innovations aimed at improving the efficiency and safety of blood transfusions and therapies derived from blood components. These innovations accelerate the clinical development of therapies used in managing conditions like cancer, anemia, and trauma recovery.

Moreover, ongoing research and development in creating new blood-based treatments for various diseases contribute to the region's strong market share. As North American healthcare institutions continue to invest in cutting-edge technologies, such as automated hematic fluid screening and artificial blood substitutes, the region is expected to maintain its leadership.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Fastest Growing Region with Highest Market Cagr

The Asia-Pacific region is witnessing the fastest growth in the global market, driven by a rising incidence of chronic illnesses like cancer, hemophilia, and immune deficiencies. This surge in demand for hematic fluid and derived products is shaping the future of the market in the region.

• For instance, in India, approximately 1.3 million people are diagnosed with cancer annually, and nearly 850,000 people died from the disease in 2020, as reported by the Indian Cancer Society.

This increasing cancer burden significantly boosts the need for hematic fluid components such as platelets and plasma for treatment. As healthcare infrastructure improves across Asia-Pacific countries, the demand for blood transfusions and related treatments continues to grow, spurring the development of blood banks, donation camps, and modern blood processing techniques.

List of Key and Emerging Players in Blood Market